{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:44:35Z","timestamp":1779317075188,"version":"3.51.4"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10741-017-9651-2","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T23:57:09Z","timestamp":1506383829000},"page":"621-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pathophysiology of acute heart failure syndrome: a knowledge gap"],"prefix":"10.1007","volume":"22","author":[{"given":"Hani N.","family":"Sabbah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"9651_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","volume":"16","author":"J Lindenfeld","year":"2010","unstructured":"Lindenfeld J, Albert NM, Boehmer JP et al (2010) HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 16:e1\u2013e194. https:\/\/doi.org\/10.1016\/j.cardfail.2010.04.004","journal-title":"J Card Fail"},{"key":"9651_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147\u2013e239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","volume":"14","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14:803\u2013869. https:\/\/doi.org\/10.1093\/eurjhf\/hfs105","journal-title":"Eur J Heart Fail"},{"key":"9651_CR4","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS et al (2016) Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation 133:e38\u2013e360. https:\/\/doi.org\/10.1161\/CIR.0000000000000350","journal-title":"Circulation"},{"key":"9651_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/aje\/kwv455","volume":"183","author":"SK Agarwal","year":"2016","unstructured":"Agarwal SK, Wruck L, Quibrera M et al (2016) Temporal trends in hospitalization for acute decompensated heart failure in the United States, 1998-2011. Am J Epidemiol 183:462\u2013470. https:\/\/doi.org\/10.1093\/aje\/kwv455","journal-title":"Am J Epidemiol"},{"key":"9651_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.amjcard.2015.04.052","volume":"116","author":"K Reynolds","year":"2015","unstructured":"Reynolds K, Butler MG, Kimes TM, Rosales AG, Chan W, Nichols GA (2015) Relation of acute heart failure hospital length of stay to subsequent readmission and all-cause mortality. Am J Cardiol 116:400\u2013405. https:\/\/doi.org\/10.1016\/j.amjcard.2015.04.052","journal-title":"Am J Cardiol"},{"key":"9651_CR7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6:606\u2013619","journal-title":"Circ Heart Fail"},{"key":"9651_CR8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","volume":"175","author":"Y Gerber","year":"2015","unstructured":"Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, Killian JM, Roger VL (2015) A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175:996\u20131004. https:\/\/doi.org\/10.1001\/jamainternmed.2015.0924","journal-title":"JAMA Intern Med"},{"key":"9651_CR9","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1001\/archinte.168.22.2481","volume":"168","author":"LH Curtis","year":"2008","unstructured":"Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF (2008) Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med 168:2481\u20132488. https:\/\/doi.org\/10.1001\/archinte.168.22.2481","journal-title":"Arch Intern Med"},{"key":"9651_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstr\u00f6m U, Filippatos G et al (2013) EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15:808\u2013817. https:\/\/doi.org\/10.1093\/eurjhf\/hft050","journal-title":"Eur J Heart Fail"},{"key":"9651_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archinte.167.5.490","volume":"167","author":"RJ Goldberg","year":"2007","unstructured":"Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA (2007) Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med 167:490\u2013496. https:\/\/doi.org\/10.1001\/archinte.167.5.490","journal-title":"Arch Intern Med"},{"key":"9651_CR12","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","volume":"297","author":"MA Konstam","year":"2007","unstructured":"Konstam MA, Gheorghiade M, Burnett JC Jr et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297:1319\u20131331. https:\/\/doi.org\/10.1001\/jama.297.12.1319","journal-title":"JAMA"},{"key":"9651_CR13","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","volume":"298","author":"JJ McMurray","year":"2007","unstructured":"McMurray JJ, Teerlink JR, Cotter G et al (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298:2009\u20132019","journal-title":"JAMA"},{"key":"9651_CR14","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","volume":"297","author":"A Mebazaa","year":"2007","unstructured":"Mebazaa A, Nieminen MS, Packer M et al (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA 297:1883\u20131891. https:\/\/doi.org\/10.1001\/jama.297.17.1883","journal-title":"JAMA"},{"key":"9651_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","volume":"363","author":"BM Massie","year":"2010","unstructured":"Massie BM, O'Connor CM, Metra M et al (2010) Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 363:1419\u20131428. https:\/\/doi.org\/10.1056\/NEJMoa0912613","journal-title":"N Engl J Med"},{"key":"9651_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1100171","volume":"365","author":"CM O'Connor","year":"2011","unstructured":"O'Connor CM, Starling RC, Hernandez AF et al (2011) Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365:32\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1100171","journal-title":"N Engl J Med"},{"key":"9651_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002947","volume":"95","author":"G Wang","year":"2016","unstructured":"Wang G, Wang P, Li Y et al (2016) Efficacy and safety of 1-hour infusion of recombinant human atrial natriuretic peptide in patients with acute decompensated heart failure: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Medicine (Baltimore) 95:e2947. https:\/\/doi.org\/10.1097\/MD.0000000000002947","journal-title":"Medicine (Baltimore)"},{"key":"9651_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrcardio.2015.134","volume":"13","author":"RJ Mentz","year":"2016","unstructured":"Mentz RJ, O'Connor CM (2016) Pathophysiology and clinical evaluation of acute heart failure. Nat Rev Cardiol 13:28\u201335. https:\/\/doi.org\/10.1038\/nrcardio.2015.134","journal-title":"Nat Rev Cardiol"},{"key":"9651_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejheart.2008.01.007","volume":"10","author":"G Cotter","year":"2008","unstructured":"Cotter G, Metra M, Milo-Cotter O, Dittrich HC, Gheorghiade M (2008) Fluid overload in acute heart failure\u2014re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10:165\u2013169. https:\/\/doi.org\/10.1016\/j.ejheart.2008.01.007","journal-title":"Eur J Heart Fail"},{"key":"9651_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","volume":"56","author":"BA Borlaug","year":"2010","unstructured":"Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM (2010) Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 56:845\u2013854. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.077","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR21","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.109.912774","volume":"121","author":"B L\u00f3pez","year":"2010","unstructured":"L\u00f3pez B, Gonz\u00e1lez A, Diez J (2010) Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 121:1645\u20131654. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.912774","journal-title":"Circulation"},{"key":"9651_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1373\/clinchem.2003.028712","volume":"50","author":"A Gegenhuber","year":"2004","unstructured":"Gegenhuber A, Mueller T, Firlinger F, Lenz K, Poelz W, Haltmayer M (2004) Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure. Clin Chem 50:454\u2013456. https:\/\/doi.org\/10.1373\/clinchem.2003.028712","journal-title":"Clin Chem"},{"key":"9651_CR23","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","volume":"110","author":"P Bettencourt","year":"2004","unstructured":"Bettencourt P, Azevedo A, Pimenta J, Fri\u00f5es F, Ferreira S, Ferreira A (2004) N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110:2168\u20132174. https:\/\/doi.org\/10.1161\/01.CIR.0000144310.04433.BE","journal-title":"Circulation"},{"key":"9651_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2003.09.044","volume":"43","author":"D Logeart","year":"2004","unstructured":"Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43:635\u2013641. https:\/\/doi.org\/10.1016\/j.jacc.2003.09.044","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR25","doi-asserted-by":"publisher","unstructured":"Gaggin HK, Truong QA, Rehman SU et al (2013) Characterization and prediction of natriuretic peptide \u201cnonresponse\u201d during heart failure management: results from the ProBNP outpatient tailored chronic heart failure (PROTECT) and the NT-proBNP-assisted treatment to lessen serial cardiac readmissions and death (BATTLESCARRED) study. Congest Heart Fail 19:135\u2013142. https:\/\/doi.org\/10.1111\/chf.12016","DOI":"10.1111\/chf.12016"},{"key":"9651_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/eurjhf\/hfs180","volume":"15","author":"RB Weiner","year":"2013","unstructured":"Weiner RB, Baggish AL, Chen-Tournoux A et al (2013) Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP outpatient tailored chronic heart failure (PROTECT) study. Eur J Heart Fail 15:342\u2013351. https:\/\/doi.org\/10.1093\/eurjhf\/hfs180","journal-title":"Eur J Heart Fail"},{"key":"9651_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archinte.166.3.315","volume":"166","author":"JL Januzzi Jr","year":"2006","unstructured":"Januzzi JL Jr, Sakhuja R, O'Donoghue M et al (2006) Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med 166:315\u2013320. https:\/\/doi.org\/10.1001\/archinte.166.3.315","journal-title":"Arch Intern Med"},{"key":"9651_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.amjcard.2007.07.066","volume":"101","author":"GC Fonarow","year":"2008","unstructured":"Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M, Wynne J, for the ADHERE Scientific Advisory Committee and Investigators (2008) Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 101:231\u2013237. https:\/\/doi.org\/10.1016\/j.amjcard.2007.07.066","journal-title":"Am J Cardiol"},{"key":"9651_CR29","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jacc.2007.12.051","volume":"51","author":"SW Waldo","year":"2008","unstructured":"Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS (2008) Pro-B-type natriuretic peptide levels in acute decompensated heart failure. J Am CollCardiol 51:1874\u20131882","journal-title":"J Am CollCardiol"},{"issue":"608\u2013611","key":"9651_CR30","first-page":"A609","volume":"84","author":"K Setsuta","year":"1999","unstructured":"Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A, Takano T, Kishida H, Hayakawa H (1999) Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84(608\u2013611):A609","journal-title":"Am J Cardiol"},{"key":"9651_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.108.844324","volume":"3","author":"A Biolo","year":"2010","unstructured":"Biolo A, Fisch M, Balog J, Chao T, Schulze PC, Ooi H, Siwik D, Colucci WS (2010) Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers. Circ Heart Fail 3:44\u201350. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.844324","journal-title":"Circ Heart Fail"},{"key":"9651_CR32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/eurjhf\/hfs110","volume":"14","author":"GM Felker","year":"2012","unstructured":"Felker GM, Hasselblad V, Tang WH et al (2012) Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. Eur J Heart Fail 14:1257\u20131264. https:\/\/doi.org\/10.1093\/eurjhf\/hfs110","journal-title":"Eur J Heart Fail"},{"key":"9651_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ehf2.12076","volume":"3","author":"AJ Meredith","year":"2016","unstructured":"Meredith AJ, Dai DL, Chen V et al (2016) Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure. ESC Heart Fail 3:86\u201396. https:\/\/doi.org\/10.1002\/ehf2.12076","journal-title":"ESC Heart Fail"},{"key":"9651_CR34","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.114.001427","volume":"7","author":"PS Jhund","year":"2014","unstructured":"Jhund PS, Claggett BL, Voors AA et al (2014) Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail 7:953\u2013959. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001427","journal-title":"Circ Heart Fail"},{"key":"9651_CR35","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","volume":"358","author":"WF Peacock IV","year":"2008","unstructured":"Peacock WF IV, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH, for the ADHERE Investigators (2008) Cardiac troponin and outcome in acute heart failure. N Engl J Med 358:2117\u20132126. https:\/\/doi.org\/10.1056\/NEJMoa0706824","journal-title":"N Engl J Med"},{"key":"9651_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ahj.2003.10.014","volume":"147","author":"MP Hudson","year":"2004","unstructured":"Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM, Gaulden LH, Sedor F, Ohman EM (2004) Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 147:546\u2013552. https:\/\/doi.org\/10.1016\/j.ahj.2003.10.014","journal-title":"Am Heart J"},{"key":"9651_CR37","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.ahj.2012.08.014","volume":"164","author":"K Bishu","year":"2012","unstructured":"Bishu K, Deswal A, Chen HH et al (2012) Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J 164:763\u2013770.e3. https:\/\/doi.org\/10.1016\/j.ahj.2012.08.014","journal-title":"Am Heart J"},{"key":"9651_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/1354750X.2015.1118539","volume":"21","author":"KJ Morine","year":"2016","unstructured":"Morine KJ, Paruchuri V, Qiao X, Mohammad N, McGraw A, Yunis A, Jaffe I, Kapur NK (2016) Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis. Biomarkers 21:91\u201397. https:\/\/doi.org\/10.3109\/1354750X.2015.1118539","journal-title":"Biomarkers"},{"key":"9651_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/eurjhf\/hfs179","volume":"15","author":"DM Kaye","year":"2013","unstructured":"Kaye DM, Khammy O, Mariani J, Maeder MT (2013) Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure. Eur J Heart Fail 15:292\u2013298. https:\/\/doi.org\/10.1093\/eurjhf\/hfs179","journal-title":"Eur J Heart Fail"},{"key":"9651_CR40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2010.04.053","volume":"151","author":"V Polyakova","year":"2011","unstructured":"Polyakova V, Loeffler I, Hein S, Miyagawa S, Piotrowska I, Dammer S, Risteli J, Schaper J, Kostin S (2011) Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP\/TIMP profiles. Int J Cardiol 151:18\u201333. https:\/\/doi.org\/10.1016\/j.ijcard.2010.04.053","journal-title":"Int J Cardiol"},{"key":"9651_CR41","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.clinbiochem.2009.06.013","volume":"42","author":"YL Ho","year":"2009","unstructured":"Ho YL, Lin YH, Lee CM et al (2009) Prognostic significance of adipocytokines and extracellular matrix activity in heart failure patients with high B-type natriuretic peptide. Clin Biochem 42:1407\u20131412. https:\/\/doi.org\/10.1016\/j.clinbiochem.2009.06.013","journal-title":"Clin Biochem"},{"key":"9651_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2143\/AC.64.1.2034358","volume":"64","author":"SV Chatzikyriakou","year":"2009","unstructured":"Chatzikyriakou SV, Tziakas DN, Chalikias GK et al (2009) Resolution of symptoms and serum peptides of collagen type I turnover in acute heart failure patients. Acta Cardiol 64:29\u201333. https:\/\/doi.org\/10.2143\/AC.64.1.2034358","journal-title":"Acta Cardiol"},{"key":"9651_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2459\/01.JCM.0000435617.86180.0b","volume":"15","author":"J L\u00f6fsj\u00f6g\u00e5rd","year":"2014","unstructured":"L\u00f6fsj\u00f6g\u00e5rd J, Kahan T, D\u00edez J, L\u00f3pez B, Gonz\u00e1lez A, Edner M, Henriksson P, Mejhert M, Persson H (2014) Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure. J Cardiovasc Med (Hagerstown) 15:463\u2013469. https:\/\/doi.org\/10.2459\/01.JCM.0000435617.86180.0b","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"9651_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ejheart.2008.09.007","volume":"10","author":"SV Chatzikyriakou","year":"2008","unstructured":"Chatzikyriakou SV, Tziakas DN, Chalikias GK et al (2008) Serum levels of collagen type-I degradation markers are associated with vascular stiffness in chronic heart failure patients. Eur J Heart Fail 10:1181\u20131185. https:\/\/doi.org\/10.1016\/j.ejheart.2008.09.007","journal-title":"Eur J Heart Fail"},{"key":"9651_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/HJR.0b013e32833ace76","volume":"19","author":"DN Tziakas","year":"2012","unstructured":"Tziakas DN, Chalikias GK, Stakos D et al (2012) Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events. Eur J Prev Cardiol 19:62\u201371. https:\/\/doi.org\/10.1097\/HJR.0b013e32833ace76","journal-title":"Eur J Prev Cardiol"},{"key":"9651_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11136-011-9932-5","volume":"21","author":"SV Chatzikyriakou","year":"2012","unstructured":"Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Papazoglou D, Lantzouraki A, Thomaidi A, Boudoulas H, Konstantinides S (2012) Circulating levels of a biomarker of collagen metabolism are associated with health-related quality of life in patients with chronic heart failure. Qual Life Res 21:143\u2013153. https:\/\/doi.org\/10.1007\/s11136-011-9932-5","journal-title":"Qual Life Res"},{"key":"9651_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.000760","volume":"1","author":"DM Gopal","year":"2012","unstructured":"Gopal DM, Kommineni M, Ayalon N et al (2012) Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc 1:e000760. https:\/\/doi.org\/10.1161\/JAHA.112.000760","journal-title":"J Am Heart Assoc"},{"key":"9651_CR48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3109\/1354750X.2012.719037","volume":"17","author":"GJ Fermann","year":"2012","unstructured":"Fermann GJ, Lindsell CJ, Storrow AB et al (2012) Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers 17:706\u2013713. https:\/\/doi.org\/10.3109\/1354750X.2012.719037","journal-title":"Biomarkers"},{"key":"9651_CR49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","volume":"167","author":"WC Meijers","year":"2014","unstructured":"Meijers WC, Januzzi JL, de Filippi C, Adourian AS, Shah SJ, van Veldhuisen DJ, de Boer RA (2014) Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. Am Heart J 167:853\u2013860.e4. https:\/\/doi.org\/10.1016\/j.ahj.2014.02.011","journal-title":"Am Heart J"},{"key":"9651_CR50","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","volume":"48","author":"RR Kimmenade van","year":"2006","unstructured":"van Kimmenade RR, Januzzi JL Jr, Ellinor PT et al (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217\u20131224. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.061","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","volume":"12","author":"RV Shah","year":"2010","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL (2010) Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail 12:826\u2013832. https:\/\/doi.org\/10.1093\/eurjhf\/hfq091","journal-title":"Eur J Heart Fail"},{"key":"9651_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2013.08.081","volume":"169","author":"FJ Carrasco-S\u00e1nchez","year":"2013","unstructured":"Carrasco-S\u00e1nchez FJ, Aramburu-Bodas O, Salamanca-Bautista P, Morales-Rull JL, Galisteo-Almeda L, P\u00e1ez-Rubio MI, Arias-Jim\u00e9nez JL, Aguayo-Canela M, P\u00e9rez-Calvo JI (2013) Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol 169:177\u2013182. https:\/\/doi.org\/10.1016\/j.ijcard.2013.08.081","journal-title":"Int J Cardiol"},{"key":"9651_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3109\/07853890.2010.538080","volume":"43","author":"RA Boer de","year":"2011","unstructured":"de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, van Veldhuisen DJ (2011) Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 43:60\u201368. https:\/\/doi.org\/10.3109\/07853890.2010.538080","journal-title":"Ann Med"},{"key":"9651_CR54","doi-asserted-by":"publisher","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538\u20131549. https:\/\/doi.org\/10.1172\/JCI30634","DOI":"10.1172\/JCI30634"},{"key":"9651_CR55","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1161\/01.CIR.0000038705.69871.D9","volume":"106","author":"EO Weinberg","year":"2002","unstructured":"Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT (2002) Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106:2961\u20132966","journal-title":"Circulation"},{"key":"9651_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","volume":"409","author":"B Dieplinger","year":"2009","unstructured":"Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer M, Mueller T (2009) Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma\u2014the presage ST2 assay. Clin Chim Acta 409:33\u201340. https:\/\/doi.org\/10.1016\/j.cca.2009.08.010","journal-title":"Clin Chim Acta"},{"key":"9651_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","volume":"50","author":"JL Januzzi Jr","year":"2007","unstructured":"Januzzi JL Jr, Peacock WF, Maisel AS et al (2007) Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (pro-brain natriuretic peptide investigation of dyspnea in the emergency department) study. J Am Coll Cardiol 50:607\u2013613. https:\/\/doi.org\/10.1016\/j.jacc.2007.05.014","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR58","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/CIRCHEARTFAILURE.108.833707","volume":"2","author":"RV Shah","year":"2009","unstructured":"Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL (2009) Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail 2:311\u2013319. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.833707","journal-title":"Circ Heart Fail"},{"key":"9651_CR59","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","volume":"52","author":"SU Rehman","year":"2008","unstructured":"Rehman SU, Mueller T, Januzzi JL Jr (2008) Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52:1458\u20131465. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.042","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR60","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/eurjhf\/hfr047","volume":"13","author":"DA Pascual-Figal","year":"2011","unstructured":"Pascual-Figal DA, Manzano-Fern\u00e1ndez S, Boronat M, Casas T, Garrido IP, Bonaque JC, Pastor-Perez F, Vald\u00e9s M, Januzzi JL (2011) Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 13:718\u2013725. https:\/\/doi.org\/10.1093\/eurjhf\/hfr047","journal-title":"Eur J Heart Fail"},{"key":"9651_CR61","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00392-015-0811-x","volume":"104","author":"F Fri\u00f5es","year":"2015","unstructured":"Fri\u00f5es F, Lourenco P, Laszczynska O, Almeida PB, Guimar\u00e3es JT, Januzzi JL, Azevedo A, Bettencourt P (2015) Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin Res Cardiol 104:491\u2013499. https:\/\/doi.org\/10.1007\/s00392-015-0811-x","journal-title":"Clin Res Cardiol"},{"key":"9651_CR62","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.amjcard.2015.01.027","volume":"115","author":"MF Yuyun","year":"2015","unstructured":"Yuyun MF, Narayan HK, Ng LL (2015) Prognostic significance of adrenomedullin in patients with heart failure and with myocardial infarction. Am J Cardiol 115:986\u2013991. https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.027","journal-title":"Am J Cardiol"},{"key":"9651_CR63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573403X12666160111125304","volume":"12","author":"M George","year":"2016","unstructured":"George M, Jena A, Srivatsan V, Muthukumar R, Dhandapani VE (2016) GDF 15\u2014a novel biomarker in the offing for heart failure. Curr Cardiol Rev 12:37\u201346","journal-title":"Curr Cardiol Rev"},{"key":"9651_CR64","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1093\/eurheartj\/ehq293","volume":"31","author":"JP Lassus","year":"2010","unstructured":"Lassus JP, Nieminen MS, Peuhkurinen K, Pulkki K, Siiril\u00e4-Waris K, Sund R, Harjola VP, FINN-AKVA study group (2010) Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 31:2791\u20132798. https:\/\/doi.org\/10.1093\/eurheartj\/ehq293","journal-title":"Eur Heart J"},{"key":"9651_CR65","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl507","volume":"28","author":"J Lassus","year":"2007","unstructured":"Lassus J, Harjola VP, Sund R, Siiril\u00e4-Waris K, Melin J, Peuhkurinen K, Pulkki K, Nieminen MS, group F-AS (2007) Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28:1841\u20131847. https:\/\/doi.org\/10.1093\/eurheartj\/ehl507","journal-title":"Eur Heart J"},{"key":"9651_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jchf.2014.06.014","volume":"3","author":"WH Tang","year":"2015","unstructured":"Tang WH, Dupont M, Hernandez AF et al (2015) Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial. JACC Heart Fail 3:40\u201349. https:\/\/doi.org\/10.1016\/j.jchf.2014.06.014","journal-title":"JACC Heart Fail"},{"key":"9651_CR67","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/ejhf.341","volume":"17","author":"GM Felker","year":"2015","unstructured":"Felker GM, Mentz RJ, Teerlink JR et al (2015) Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail 17:1262\u20131270. https:\/\/doi.org\/10.1002\/ejhf.341","journal-title":"Eur J Heart Fail"},{"key":"9651_CR68","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.amjcard.2012.06.035","volume":"110","author":"K Shrestha","year":"2012","unstructured":"Shrestha K, Shao Z, Singh D, Dupont M, Tang WH (2012) Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Am J Cardiol 110:1329\u20131335. https:\/\/doi.org\/10.1016\/j.amjcard.2012.06.035","journal-title":"Am J Cardiol"},{"key":"9651_CR69","doi-asserted-by":"publisher","first-page":"3708210","DOI":"10.1155\/2016\/3708210","volume":"2016","author":"S Angeletti","year":"2016","unstructured":"Angeletti S, Fogolari M, Morolla D et al (2016) Role of neutrophil gelatinase-associated lipocalin in the diagnosis and early treatment of acute kidney injury in a case series of patients with acute decompensated heart failure: a case series. Cardiol Res Pract 2016:3708210. https:\/\/doi.org\/10.1155\/2016\/3708210","journal-title":"Cardiol Res Pract"},{"key":"9651_CR70","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/eurjhf\/hfs087","volume":"14","author":"SP Collins","year":"2012","unstructured":"Collins SP, Hart KW, Lindsell CJ et al (2012) Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Eur J Heart Fail 14:1020\u20131029. https:\/\/doi.org\/10.1093\/eurjhf\/hfs087","journal-title":"Eur J Heart Fail"},{"key":"9651_CR71","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.amjcard.2015.03.043","volume":"116","author":"A Palazzuoli","year":"2015","unstructured":"Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C (2015) Comparison of neutrophil gelatinase-associated lipocalin versus B-type natriuretic peptide and cystatin C to predict early acute kidney injury and outcome in patients with acute heart failure. Am J Cardiol 116:104\u2013111. https:\/\/doi.org\/10.1016\/j.amjcard.2015.03.043","journal-title":"Am J Cardiol"},{"key":"9651_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/17482941.2014.911915","volume":"16","author":"A Palazzuoli","year":"2014","unstructured":"Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C (2014) Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Acute Card Care 16:93\u2013101. https:\/\/doi.org\/10.3109\/17482941.2014.911915","journal-title":"Acute Card Care"},{"key":"9651_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijcard.2011.07.080","volume":"165","author":"M Alvelos","year":"2013","unstructured":"Alvelos M, Lourenco P, Dias C, Amorim M, Rema J, Leite AB, Guimar\u00e3es JT, Almeida P, Bettencourt P (2013) Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol 165:51\u201355. https:\/\/doi.org\/10.1016\/j.ijcard.2011.07.080","journal-title":"Int J Cardiol"},{"key":"9651_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCHEARTFAILURE.113.000242","volume":"7","author":"VM Deursen van","year":"2014","unstructured":"van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL (2014) Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. Circ Heart Fail 7:35\u201342. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000242","journal-title":"Circ Heart Fail"},{"key":"9651_CR75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cardfail.2009.07.003","volume":"16","author":"A Aghel","year":"2010","unstructured":"Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH (2010) Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 16:49\u201354. https:\/\/doi.org\/10.1016\/j.cardfail.2009.07.003","journal-title":"J Card Fail"},{"key":"9651_CR76","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/eurjhf\/hfs039","volume":"14","author":"M Dupont","year":"2012","unstructured":"Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M, Maroo AP, Tang WH (2012) Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 14:597\u2013604. https:\/\/doi.org\/10.1093\/eurjhf\/hfs039","journal-title":"Eur J Heart Fail"},{"key":"9651_CR77","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cardfail.2013.07.004","volume":"19","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Dupont M, Shao Z, Shrestha K, Singh D, Finucan M, Mullens W, Tang WH (2013) Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure. J Card Fail 19:621\u2013628. https:\/\/doi.org\/10.1016\/j.cardfail.2013.07.004","journal-title":"J Card Fail"},{"key":"9651_CR78","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/cc10600","volume":"16","author":"T Breidthardt","year":"2012","unstructured":"Breidthardt T, Socrates T, Drexler B et al (2012) Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 16:R2. https:\/\/doi.org\/10.1186\/cc10600","journal-title":"Crit Care"},{"key":"9651_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cca.2014.10.041","volume":"443","author":"A Bouquegneau","year":"2015","unstructured":"Bouquegneau A, Krzesinski JM, Delanaye P, Cavalier E (2015) Biomarkers and physiopathology in the cardiorenal syndrome. Clin Chim Acta 443:100\u2013107. https:\/\/doi.org\/10.1016\/j.cca.2014.10.041","journal-title":"Clin Chim Acta"},{"key":"9651_CR80","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jchf.2015.06.006","volume":"3","author":"JL Grodin","year":"2015","unstructured":"Grodin JL, Perez AL, Wu Y et al (2015) Circulating kidney injury molecule-1 levels in acute heart failure: insights from the ASCEND-HF trial (acute study of clinical effectiveness of nesiritide in decompensated heart failure). JACC Heart Fail 3:777\u2013785. https:\/\/doi.org\/10.1016\/j.jchf.2015.06.006","journal-title":"JACC Heart Fail"},{"key":"9651_CR81","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","volume":"14","author":"AP Ambrosy","year":"2012","unstructured":"Ambrosy AP, Vaduganathan M, Huffman MD et al (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302\u2013311. https:\/\/doi.org\/10.1093\/eurjhf\/hfs007","journal-title":"Eur J Heart Fail"},{"key":"9651_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100618","volume":"9","author":"S Abe","year":"2014","unstructured":"Abe S, Yoshihisa A, Takiguchi M et al (2014) Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One 9:e100618. https:\/\/doi.org\/10.1371\/journal.pone.0100618","journal-title":"PLoS One"},{"key":"9651_CR83","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","volume":"37","author":"T Tsutamoto","year":"2001","unstructured":"Tsutamoto T, Wada A, Maeda K et al (2001) Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37:1228\u20131233","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR84","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/eurheartj\/ehl505","volume":"28","author":"FM Fruhwald","year":"2007","unstructured":"Fruhwald FM, Fahrleitner-Pammer A, Berger R et al (2007) Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28:1592\u20131597. https:\/\/doi.org\/10.1093\/eurheartj\/ehl505","journal-title":"Eur Heart J"},{"key":"9651_CR85","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","volume":"107","author":"IS Anand","year":"2003","unstructured":"Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 107:1278\u20131283","journal-title":"Circulation"},{"key":"9651_CR86","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.cardfail.2012.05.005","volume":"18","author":"HK Gaggin","year":"2012","unstructured":"Gaggin HK, Mohammed AA, Bhardwaj A et al (2012) Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. J Card Fail 18:626\u2013634. https:\/\/doi.org\/10.1016\/j.cardfail.2012.05.005","journal-title":"J Card Fail"},{"key":"9651_CR87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ahj.2012.08.015","volume":"164","author":"A Bhardwaj","year":"2012","unstructured":"Bhardwaj A, Rehman SU, Mohammed AA, Gaggin HK, Barajas L, Barajas J, Moore SA, Sullivan D, Januzzi JL (2012) Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. Am Heart J 164:793\u2013799.e1. https:\/\/doi.org\/10.1016\/j.ahj.2012.08.015","journal-title":"Am Heart J"},{"key":"9651_CR88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00944780","volume":"147","author":"HN Sabbah","year":"1995","unstructured":"Sabbah HN, Sharov VG, Lesch M, Goldstein S (1995) Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem 147:29\u201334","journal-title":"Mol Cell Biochem"},{"key":"9651_CR89","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","volume":"11","author":"RA Boer de","year":"2009","unstructured":"de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ (2009) Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 11:811\u2013817. https:\/\/doi.org\/10.1093\/eurjhf\/hfp097","journal-title":"Eur J Heart Fail"},{"key":"9651_CR90","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00392-012-0500-y","volume":"102","author":"DJ Lok","year":"2013","unstructured":"Lok DJ, Lok SI, Bruggink-Andr\u00e9 de la Porte PW, Badings E, Lipsic E, van Wijngaarden J, de Boer RA, van Veldhuisen DJ, van der Meer P (2013) Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 102:103\u2013110. https:\/\/doi.org\/10.1007\/s00392-012-0500-y","journal-title":"Clin Res Cardiol"},{"key":"9651_CR91","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","volume":"13","author":"JT Heywood","year":"2007","unstructured":"Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, for the ADHERE Scientific Advisory Committee and Investigators (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422\u2013430. https:\/\/doi.org\/10.1016\/j.cardfail.2007.03.011","journal-title":"J Card Fail"},{"key":"9651_CR92","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","volume":"168","author":"GC Fonarow","year":"2008","unstructured":"Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168:847\u2013854","journal-title":"Arch Intern Med"},{"key":"9651_CR93","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ahj.2011.12.003","volume":"163","author":"MT Maeder","year":"2012","unstructured":"Maeder MT, Rickli H, Pfisterer ME et al (2012) Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. Am Heart J 163:407\u2013414, 414.e1. https:\/\/doi.org\/10.1016\/j.ahj.2011.12.003","journal-title":"Am Heart J"},{"key":"9651_CR94","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/AC.69.6.1000008","volume":"69","author":"E Abo-Salem","year":"2014","unstructured":"Abo-Salem E, Sherif K, Dunlap S, Prabhakar S (2014) Potential aetiologies and prognostic implications of worsening renal function in acute decompensated heart failure. Acta Cardiol 69:657\u2013663","journal-title":"Acta Cardiol"},{"key":"9651_CR95","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001174","volume":"3","author":"T Ueda","year":"2014","unstructured":"Ueda T, Kawakami R, Sugawara Y et al (2014) Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure. J Am Heart Assoc 3:e001174. https:\/\/doi.org\/10.1161\/JAHA.114.001174","journal-title":"J Am Heart Assoc"},{"key":"9651_CR96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000349969","volume":"182","author":"M Haase","year":"2013","unstructured":"Haase M, M\u00fcller C, Damman K, Murray PT, Kellum JA, Ronco C, McCullough PA (2013) Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol 182:99\u2013116. https:\/\/doi.org\/10.1159\/000349969","journal-title":"Contrib Nephrol"},{"key":"9651_CR97","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1093\/eurheartj\/ehs205","volume":"33","author":"M Metra","year":"2012","unstructured":"Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA (2012) The role of the kidney in heart failure. Eur Heart J 33:2135\u20132142. https:\/\/doi.org\/10.1093\/eurheartj\/ehs205","journal-title":"Eur Heart J"},{"key":"9651_CR98","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ejhf.210","volume":"17","author":"HP Brunner-La Rocca","year":"2015","unstructured":"Brunner-La Rocca HP, Knackstedt C, Eurlings L et al (2015) Impact of worsening renal function related to medication in heart failure. Eur J Heart Fail 17:159\u2013168. https:\/\/doi.org\/10.1002\/ejhf.210","journal-title":"Eur J Heart Fail"},{"key":"9651_CR99","doi-asserted-by":"publisher","first-page":"R134","DOI":"10.1186\/cc13952","volume":"18","author":"A Palazzuoli","year":"2014","unstructured":"Palazzuoli A, Pellegrini M, Ruocco G et al (2014) Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial. Crit Care 18:R134. https:\/\/doi.org\/10.1186\/cc13952","journal-title":"Crit Care"},{"key":"9651_CR100","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA et al (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364:797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419","journal-title":"N Engl J Med"},{"key":"9651_CR101","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1111\/chf.12015","volume":"19","author":"M Dupont","year":"2013","unstructured":"Dupont M, Shrestha K, Singh D, Finucan M, Tang WH (2013) Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C. Congest Heart Fail 19:E17\u2013E21. https:\/\/doi.org\/10.1111\/chf.12015","journal-title":"Congest Heart Fail"},{"key":"9651_CR102","doi-asserted-by":"publisher","unstructured":"Bjurman C, Jensen J, Petzold M, Hammarsten O, Fu ML (2013) Assessment of a multimarker strategy for prediction of mortality in older heart failure patients: a cohort study. BMJ Open 3. https:\/\/doi.org\/10.1136\/bmjopen-2012-002254","DOI":"10.1136\/bmjopen-2012-002254"},{"key":"9651_CR103","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/clc.22362","volume":"38","author":"PJ Flores-Blanco","year":"2015","unstructured":"Flores-Blanco PJ, Manzano-Fern\u00e1ndez S, P\u00e9rez-Calvo JI et al (2015) Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure. Clin Cardiol 38:106\u2013113. https:\/\/doi.org\/10.1002\/clc.22362","journal-title":"Clin Cardiol"},{"key":"9651_CR104","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jacc.2016.06.055","volume":"68","author":"AS Maisel","year":"2016","unstructured":"Maisel AS, Wettersten N, van Veldhuisen DJ et al (2016) Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol 68:1420\u20131431. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.055","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR105","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/ejhf.746","volume":"19","author":"M Sokolski","year":"2017","unstructured":"Sokolski M, Zymlinski R, Biegus J et al (2017) Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail 19:760\u2013767. https:\/\/doi.org\/10.1002\/ejhf.746","journal-title":"Eur J Heart Fail"},{"key":"9651_CR106","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246","volume":"6","author":"RD Kociol","year":"2013","unstructured":"Kociol RD, McNulty SE, Hernandez AF et al (2013) Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 6:240\u2013245. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.969246","journal-title":"Circ Heart Fail"},{"key":"9651_CR107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1161\/CIRCHEARTFAILURE.112.970335","volume":"6","author":"A Solomonica","year":"2013","unstructured":"Solomonica A, Burger AJ, Aronson D (2013) Hemodynamic determinants of dyspnea improvement in acute decompensated heart failure. Circ Heart Fail 6:53\u201360. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.970335","journal-title":"Circ Heart Fail"},{"key":"9651_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink JR, Cotter G, Davison BA et al (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381:29\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(12)61855-8","journal-title":"Lancet"},{"key":"9651_CR109","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/eurheartj\/eht459","volume":"35","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Mitrovic V, Ruda M et al (2014) A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J 35:431\u2013441. https:\/\/doi.org\/10.1093\/eurheartj\/eht459","journal-title":"Eur Heart J"},{"key":"9651_CR110","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.recesp.2011.05.006","volume":"64","author":"L Pappas","year":"2011","unstructured":"Pappas L, Filippatos G (2011) Pulmonary congestion in acute heart failure: from hemodynamics to lung injury and barrier dysfunction. Rev Esp Cardiol 64:735\u2013738. https:\/\/doi.org\/10.1016\/j.recesp.2011.05.006","journal-title":"Rev Esp Cardiol"},{"key":"9651_CR111","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1152\/jappl.2000.89.6.2483","volume":"89","author":"JB West","year":"2000","unstructured":"West JB (2000) Invited review: pulmonary capillary stress failure. J Appl Physiol (1985) 89:2483\u20132489 discussion 2497","journal-title":"J Appl Physiol (1985)"},{"key":"9651_CR112","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1152\/jappl.1992.73.3.1150","volume":"73","author":"AR Elliott","year":"1992","unstructured":"Elliott AR, Fu Z, Tsukimoto K, Prediletto R, Mathieu-Costello O, West JB (1992) Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol (1985) 73:1150\u20131158","journal-title":"J Appl Physiol (1985)"},{"key":"9651_CR113","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.CCM.0000059649.31659.22","volume":"31","author":"CG Pasquale De","year":"2003","unstructured":"De Pasquale CG, Arnolda LF, Doyle IR, Grant RL, Aylward PE, Bersten AD (2003) Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema. Crit Care Med 31:1060\u20131067. https:\/\/doi.org\/10.1097\/01.CCM.0000059649.31659.22","journal-title":"Crit Care Med"},{"key":"9651_CR114","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0008-6363(99)00348-X","volume":"45","author":"HN Sabbah","year":"2000","unstructured":"Sabbah HN (2000) Apoptotic cell death in heart failure. Cardiovasc Res 45:704\u2013712","journal-title":"Cardiovasc Res"},{"key":"9651_CR115","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jchf.2015.01.007","volume":"3","author":"BA Davison","year":"2015","unstructured":"Davison BA, Metra M, Cotter G et al (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC Heart Fail 3:395\u2013403. https:\/\/doi.org\/10.1016\/j.jchf.2015.01.007","journal-title":"JACC Heart Fail"},{"key":"9651_CR116","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ahj.2015.04.007","volume":"170","author":"JP Kelly","year":"2015","unstructured":"Kelly JP, Mentz RJ, Hasselblad V et al (2015) Worsening heart failure during hospitalization for acute heart failure: insights from the acute study of clinical effectiveness of nesiritide in decompensated heart failure (ASCEND-HF). Am Heart J 170:298\u2013305. https:\/\/doi.org\/10.1016\/j.ahj.2015.04.007","journal-title":"Am Heart J"},{"key":"9651_CR117","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cardfail.2009.04.001","volume":"15","author":"G Torre-Amione","year":"2009","unstructured":"Torre-Amione G, Milo-Cotter O, Kaluski E, Perchenet L, Kobrin I, Frey A, Rund MM, Weatherley BD, Cotter G (2009) Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcome. J Card Fail 15:639\u2013644. https:\/\/doi.org\/10.1016\/j.cardfail.2009.04.001","journal-title":"J Card Fail"},{"key":"9651_CR118","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ahj.2014.08.008","volume":"168","author":"SN Levin","year":"2014","unstructured":"Levin SN, Hajduk AM, McManus DD, Darling CE, Gurwitz JH, Spencer FA, Goldberg RJ, Saczynski JS (2014) Cognitive status in patients hospitalized with acute decompensated heart failure. Am Heart J 168:917\u2013923. https:\/\/doi.org\/10.1016\/j.ahj.2014.08.008","journal-title":"Am Heart J"},{"key":"9651_CR119","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/ejhf.241","volume":"17","author":"MA Woo","year":"2015","unstructured":"Woo MA, Ogren JA, Abouzeid CM et al (2015) Regional hippocampal damage in heart failure. Eur J Heart Fail 17:494\u2013500. https:\/\/doi.org\/10.1002\/ejhf.241","journal-title":"Eur J Heart Fail"},{"key":"9651_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126595","volume":"10","author":"R Kumar","year":"2015","unstructured":"Kumar R, Yadav SK, Palomares JA et al (2015) Reduced regional brain cortical thickness in patients with heart failure. PLoS One 10:e0126595. https:\/\/doi.org\/10.1371\/journal.pone.0126595","journal-title":"PLoS One"},{"key":"9651_CR121","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/gps.4023","volume":"29","author":"ML Alosco","year":"2014","unstructured":"Alosco ML, Spitznagel MB, Cohen R, Raz N, Sweet LH, Josephson R, Hughes J, Rosneck J, Gunstad J (2014) Reduced cerebral perfusion predicts greater depressive symptoms and cognitive dysfunction at a 1-year follow-up in patients with heart failure. Int J Geriatr Psychiatry 29:428\u2013436. https:\/\/doi.org\/10.1002\/gps.4023","journal-title":"Int J Geriatr Psychiatry"},{"key":"9651_CR122","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.ejheart.2007.07.006","volume":"9","author":"RL Vogels","year":"2007","unstructured":"Vogels RL, van der Flier WM, van Harten B, Gouw AA, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Brain magnetic resonance imaging abnormalities in patients with heart failure. Eur J Heart Fail 9:1003\u20131009. https:\/\/doi.org\/10.1016\/j.ejheart.2007.07.006","journal-title":"Eur J Heart Fail"},{"key":"9651_CR123","doi-asserted-by":"publisher","first-page":"82.e1","DOI":"10.1016\/j.ahj.2006.10.008","volume":"153","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Abraham WT, Albert NM et al (2007) Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). Am Heart J 153:82.e1\u201382.11. https:\/\/doi.org\/10.1016\/j.ahj.2006.10.008","journal-title":"Am Heart J"},{"key":"9651_CR124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-015-0106-5","volume":"7","author":"JA Cannon","year":"2015","unstructured":"Cannon JA, McMurray JJ, Quinn TJ (2015) \u2018Hearts and minds\u2019: association, causation and implication of cognitive impairment in heart failure. Alzheimers Res Ther 7:22. https:\/\/doi.org\/10.1186\/s13195-015-0106-5","journal-title":"Alzheimers Res Ther"},{"key":"9651_CR125","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11897-010-0009-5","volume":"7","author":"A Ganda","year":"2010","unstructured":"Ganda A, Onat D, Demmer RT, Wan E, Vittorio TJ, Sabbah HN, Colombo PC (2010) Venous congestion and endothelial cell activation in acute decompensated heart failure. Curr Heart Fail Rep 7:66\u201374. https:\/\/doi.org\/10.1007\/s11897-010-0009-5","journal-title":"Curr Heart Fail Rep"},{"key":"9651_CR126","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","volume":"60","author":"CN Marti","year":"2012","unstructured":"Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60:1455\u20131469. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.082","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR127","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1071-9164(00)00009-9","volume":"6","author":"PC Lee","year":"2000","unstructured":"Bank AJ, Lee PC, Kubo SH (2000) Endothelial dysfunction in patients with heart failure: relationship to disease severity. J Card Fail 6:29\u201336","journal-title":"J Card Fail"},{"key":"9651_CR128","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/eurheartj\/ehi001","volume":"26","author":"D Fischer","year":"2005","unstructured":"Fischer D, Rossa S, Landmesser U, Spiekermann S, Engberding N, Hornig B, Drexler H (2005) Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 26:65\u201369. https:\/\/doi.org\/10.1093\/eurheartj\/ehi001","journal-title":"Eur Heart J"},{"key":"9651_CR129","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/01.CIR.0000153349.77489.CF","volume":"111","author":"SD Katz","year":"2005","unstructured":"Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, Yasskiy A (2005) Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111:310\u2013314. https:\/\/doi.org\/10.1161\/01.CIR.0000153349.77489.CF","journal-title":"Circulation"},{"key":"9651_CR130","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jacc.2005.04.060","volume":"46","author":"B Meyer","year":"2005","unstructured":"Meyer B, M\u00f6rtl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, Pacher R, Berger R (2005) Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 46:1011\u20131018. https:\/\/doi.org\/10.1016\/j.jacc.2005.04.060","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR131","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/eurjhf\/hfp053","volume":"11","author":"M Shechter","year":"2009","unstructured":"Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D (2009) Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 11:588\u2013593. https:\/\/doi.org\/10.1093\/eurjhf\/hfp053","journal-title":"Eur J Heart Fail"},{"key":"9651_CR132","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/eurjhf\/hfq036","volume":"12","author":"JR Berrazueta de","year":"2010","unstructured":"de Berrazueta JR, Guerra-Ruiz A, Garc\u00eda-Unzueta MT, Toca GM, Laso RS, de Adana MS, Martin MA, Cobo M, Llorca J (2010) Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. Eur J Heart Fail 12:477\u2013483. https:\/\/doi.org\/10.1093\/eurjhf\/hfq036","journal-title":"Eur J Heart Fail"},{"key":"9651_CR133","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ejhf.456","volume":"18","author":"AL Perez","year":"2016","unstructured":"Perez AL, Grodin JL, Wu Y et al (2016) Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy. Eur J Heart Fail 18:290\u2013297. https:\/\/doi.org\/10.1002\/ejhf.456","journal-title":"Eur J Heart Fail"},{"key":"9651_CR134","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/eurheartj\/eht456","volume":"35","author":"PC Colombo","year":"2014","unstructured":"Colombo PC, Onat D, Harxhi A et al (2014) Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation. Eur Heart J 35:448\u2013454. https:\/\/doi.org\/10.1093\/eurheartj\/eht456","journal-title":"Eur Heart J"},{"key":"9651_CR135","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/joic.12269","volume":"29","author":"M Abdel Hamid","year":"2016","unstructured":"Abdel Hamid M, Bakhoum SW, Sharaf Y, Sabry D, El-Gengehe AT, Abdel-Latif A (2016) Circulating endothelial cells and endothelial function predict major adverse cardiac events and early adverse left ventricular remodeling in patients with ST-segment elevation myocardial infarction. J Interv Cardiol 29:89\u201398. https:\/\/doi.org\/10.1111\/joic.12269","journal-title":"J Interv Cardiol"},{"key":"9651_CR136","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11897-015-0254-8","volume":"12","author":"PC Colombo","year":"2015","unstructured":"Colombo PC, Doran AC, Onat D, Wong KY, Ahmad M, Sabbah HN, Demmer RT (2015) Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect? Curr Heart Fail Rep 12:215\u2013222. https:\/\/doi.org\/10.1007\/s11897-015-0254-8","journal-title":"Curr Heart Fail Rep"},{"key":"9651_CR137","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/01.RES.0000145728.22878.45","volume":"95","author":"GP Sorescu","year":"2004","unstructured":"Sorescu GP, Song H, Tressel SL et al (2004) Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circ Res 95:773\u2013779. https:\/\/doi.org\/10.1161\/01.RES.0000145728.22878.45","journal-title":"Circ Res"},{"key":"9651_CR138","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, M\u00fcnzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916\u20131923. https:\/\/doi.org\/10.1172\/JCI118623","journal-title":"J Clin Invest"},{"key":"9651_CR139","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejheart.2007.12.007","volume":"10","author":"PC Colombo","year":"2008","unstructured":"Colombo PC, Onat D, Sabbah HN (2008) Acute heart failure as \u201cacute endothelitis\u201d\u2014interaction of fluid overload and endothelial dysfunction. Eur J Heart Fail 10:170\u2013175. https:\/\/doi.org\/10.1016\/j.ejheart.2007.12.007","journal-title":"Eur J Heart Fail"},{"key":"9651_CR140","unstructured":"Packer M Short and long-term effect of immediate vasodilator therapy in acutely decompensated heart failure: results of the TRUE-AHF trial. Presented at: American Heart Association Annual Meeting, November 13, 3016, New Orleans, LA"},{"key":"9651_CR141","unstructured":"ClinicalTrials.gov . Efficacy, safety and tolerability of serelaxin when added to standard therapy in AHF (RELAX-AHF-2). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01870778 . Accessed 24 Mar 2017"},{"key":"9651_CR142","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/ejhf.830","volume":"19","author":"JR Teerlink","year":"2017","unstructured":"Teerlink JR, Voors AA, Ponikowski P et al (2017) Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Eur J Heart Fail 19:800\u2013809. https:\/\/doi.org\/10.1002\/ejhf.830","journal-title":"Eur J Heart Fail"},{"key":"9651_CR143","unstructured":"Novartis provides update on Phase III study of RLX030 (serelaxin) in patients with acute heart failure. Published March 22, 2017. https:\/\/www.novartis.com\/news\/media-releases\/novartis-provides-update-phase-iii-study-rlx030-serelaxin-patients-acute-heart . Accessed 8 May 2017"},{"key":"9651_CR144","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0008-6363(01)00331-5","volume":"51","author":"W Forssmann","year":"2001","unstructured":"Forssmann W, Meyer M, Forssmann K (2001) The renal urodilatin system: clinical implications. Cardiovasc Res 51:450\u2013462","journal-title":"Cardiovasc Res"},{"key":"9651_CR145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20150469","volume":"130","author":"M Volpe","year":"2016","unstructured":"Volpe M, Carnovali M, Mastromarino V (2016) The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci (Lond) 130:57\u201377. https:\/\/doi.org\/10.1042\/CS20150469","journal-title":"Clin Sci (Lond)"},{"key":"9651_CR146","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.HYP.16.3.269","volume":"16","author":"M Richards","year":"1990","unstructured":"Richards M, Espiner E, Frampton C, Ikram H, Yandle T, Sopwith M, Cussans N (1990) Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects. Hypertension 16:269\u2013276","journal-title":"Hypertension"},{"key":"9651_CR147","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1210\/jcem.84.2.5489","volume":"84","author":"JG Lainchbury","year":"1999","unstructured":"Lainchbury JG, Richards AM, Nicholls MG, Espiner EA, Yandle TG (1999) Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment. J Clin Endocrinol Metab 84:723\u2013729. https:\/\/doi.org\/10.1210\/jcem.84.2.5489","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR148","doi-asserted-by":"publisher","first-page":"L973","DOI":"10.1152\/ajplung.00033.2003","volume":"285","author":"AM Hamad","year":"2003","unstructured":"Hamad AM, Clayton A, Islam B, Knox AJ (2003) Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol 285:L973\u2013L983. https:\/\/doi.org\/10.1152\/ajplung.00033.2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9651_CR149","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbrc.2004.07.119","volume":"322","author":"D Hayashi","year":"2004","unstructured":"Hayashi D, Kudoh S, Shiojima I et al (2004) Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1. Biochem Biophys Res Commun 322:310\u2013319. https:\/\/doi.org\/10.1016\/j.bbrc.2004.07.119","journal-title":"Biochem Biophys Res Commun"},{"key":"9651_CR150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.RES.74.4.747","volume":"74","author":"RW Barbee","year":"1994","unstructured":"Barbee RW, Perry BD, Re RN, Murgo JP, Field LJ (1994) Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor. Circ Res 74:747\u2013751","journal-title":"Circ Res"},{"key":"9651_CR151","first-page":"606","volume":"38","author":"MA Miyares","year":"2013","unstructured":"Miyares MA, Davis KA (2013) Serelaxin, a \u201cbreakthrough\u201d investigational intravenous agent for acute heart failure. P T 38:606\u2013611","journal-title":"P T"},{"key":"9651_CR152","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jacc.2012.11.005","volume":"61","author":"M Metra","year":"2013","unstructured":"Metra M, Cotter G, Davison BA et al (2013) Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61:196\u2013206. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.005","journal-title":"J Am Coll Cardiol"},{"key":"9651_CR153","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ejhf.331","volume":"17","author":"G Cotter","year":"2015","unstructured":"Cotter G, Voors AA, Prescott MF et al (2015) Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study. Eur J Heart Fail 17:1133\u20131143. https:\/\/doi.org\/10.1002\/ejhf.331","journal-title":"Eur J Heart Fail"},{"key":"9651_CR154","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000285","volume":"3","author":"JI Hoffman","year":"2014","unstructured":"Hoffman JI, Buckberg GD (2014) The myocardial oxygen supply:demand index revisited. J Am Heart Assoc 3:e000285. https:\/\/doi.org\/10.1161\/JAHA.113.000285","journal-title":"J Am Heart Assoc"},{"key":"9651_CR155","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.amjmed.2006.09.012","volume":"119","author":"HH Chen","year":"2006","unstructured":"Chen HH, Schrier RW (2006) Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119:S11\u2013S16. https:\/\/doi.org\/10.1016\/j.amjmed.2006.09.012","journal-title":"Am J Med"},{"key":"9651_CR156","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2015.01.005","volume":"21","author":"PA Gorski","year":"2015","unstructured":"Gorski PA, Ceholski DK, Hajjar RJ (2015) Altered myocardial calcium cycling and energetics in heart failure\u2014a rational approach for disease treatment. Cell Metab 21:183\u2013194. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.005","journal-title":"Cell Metab"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-017-9651-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-017-9651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:38:25Z","timestamp":1570131505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-017-9651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":156,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["9651"],"URL":"https:\/\/doi.org\/10.1007\/s10741-017-9651-2","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]}}}